These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6978336)

  • 1. The dual role of factor VII in blood coagulation. Initiation and inhibition of a proteolytic system by a zymogen.
    Zur M; Radcliffe RD; Oberdick J; Nemerson Y
    J Biol Chem; 1982 May; 257(10):5623-31. PubMed ID: 6978336
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of the initiation of coagulation by factor VII.
    Nemerson Y
    Haemostasis; 1983; 13(3):150-5. PubMed ID: 6350119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of factor VII in the intrinsic pathway: a brief review.
    Prydz H
    Haemostasis; 1983; 13(3):156-60. PubMed ID: 6350120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of human factor VII in the initiation of tissue factor-dependent coagulation.
    Rao LV; Rapaport SI; Bajaj SP
    Blood; 1986 Sep; 68(3):685-91. PubMed ID: 3488776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Activation of coagulation in phospholipid phase].
    Suzuki K
    Rinsho Byori; 1985 Sep; 33(9):966-73. PubMed ID: 3878417
    [No Abstract]   [Full Text] [Related]  

  • 6. Half-life time and control frequency of vitamin K-dependent Coagulation factors. Theoretical considerations on the place of factor VII in the control of oral anticoagulation therapy.
    van Dam-Mieras MC; Hemker HC
    Haemostasis; 1983; 13(3):201-8. PubMed ID: 6350124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activation of factor IX by the tissue factor pathway.
    Rapaport SI
    Prog Clin Biol Res; 1981; 72():57-76. PubMed ID: 7335650
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of tissue factor/factor VIIa activity in plasma requires factor X and an additional plasma component.
    Sanders NL; Bajaj SP; Zivelin A; Rapaport SI
    Blood; 1985 Jul; 66(1):204-12. PubMed ID: 3873968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of human factor VII by activated factors IX and X.
    Masys DR; Bajaj SP; Rapaport SI
    Blood; 1982 Nov; 60(5):1143-50. PubMed ID: 7126868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian rhythms of blood clotting time and coagulation factors II, VII, IX and X in rats.
    Soulban G; Labrecque G
    Life Sci; 1989; 45(25):2485-9. PubMed ID: 2607889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation.
    Rao LV; Rapaport SI
    Blood; 1987 Feb; 69(2):645-51. PubMed ID: 3492226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-damping mechanism in blood coagulation.
    Nemerson Y; Silverberg SA; Jesty J
    Thromb Diath Haemorrh; 1974 Sep; 32(1):57-64. PubMed ID: 4454045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of serine proteases in the blood coagulation cascade.
    Davie EW; Fujikawa K; Kurachi K; Kisiel W
    Adv Enzymol Relat Areas Mol Biol; 1979; 48():277-318. PubMed ID: 367103
    [No Abstract]   [Full Text] [Related]  

  • 14. Activation of 125I-factor IX and 125I-factor X: effect of tissue factor and factor VII, factor Xa and thrombin.
    Osterud B; Rapaport SI
    Scand J Haematol; 1980 Mar; 24(3):213-26. PubMed ID: 7375819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of blood coagulation.
    Owren PA; Stormorken H
    Ergeb Physiol; 1973; 68():1-53. PubMed ID: 4593726
    [No Abstract]   [Full Text] [Related]  

  • 16. The normal coagulation mechanism.
    Bennett B; Ratnoff OD
    Med Clin North Am; 1972 Jan; 56(1):95-104. PubMed ID: 4550195
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of activated factors II, VII, IX, and X by synthetic organic compounds directed against the active-site seryl residue.
    Van der Woerd-de Lange JA; van Dam-Mieras MC; Hemker HC
    Haemostasis; 1981; 10(6):315-47. PubMed ID: 6976920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of human factor VII during clotting in vitro.
    Rao LV; Bajaj SP; Rapaport SI
    Blood; 1985 Jan; 65(1):218-26. PubMed ID: 3871163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation pathways of the coagulation system in normal haemostasis.
    Osterud B
    Scand J Haematol; 1984 Apr; 32(4):337-45. PubMed ID: 6372076
    [No Abstract]   [Full Text] [Related]  

  • 20. The regulation of the factor VII-dependent coagulation pathway: rationale for the effectiveness of recombinant factor VIIa in refractory bleeding disorders.
    van't Veer C; Mann KG
    Semin Thromb Hemost; 2000; 26(4):367-72. PubMed ID: 11092210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.